Insider Transactions in Q3 2025 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2025
|
Kathleen D. Scott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-55.45%
|
$187,500
$15.0 P/Share
|
|
Aug 21
2025
|
Kathleen D. Scott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+35.67%
|
$12,500
$1.5 P/Share
|
|
Aug 21
2025
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-4.01%
|
$700,000
$14.49 P/Share
|
|
Aug 20
2025
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
37,656
-2.93%
|
$527,184
$14.09 P/Share
|
|
Aug 19
2025
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
12,344
-0.95%
|
$172,816
$14.03 P/Share
|
|
Jul 01
2025
|
Eric Karas Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-59.25%
|
$240,000
$16.99 P/Share
|
|
Jul 01
2025
|
Eric Karas Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+37.21%
|
$15,000
$1.5 P/Share
|